Ampersand Capital Partners, a healthcare-focused middle market private equity firm, has made three additions to its management team.
Eric Lev has joined Ampersand as a partner, bringing over 12 years of middle market healthcare investing experience. Lev was most recently at Water Street Healthcare Partners where he served on the investment team since Water Street’s formation in 2005.
While at Water Street, Lev played a key role in helping to build the firm’s practices in life sciences and diagnostics. Prior to Water Street, he worked at Beckman Coulter and at One Equity Partners.
Dana Niles has joined Ampersand as the firm’s chief financial officer and chief compliance officer. Prior to Ampersand, Niles served as CFO of HighPoint Capital, a senior debt platform acquired by Crescent Capital in 2012. Before HighPoint, Niles served as controller at both HLM Venture Partners and YankeeTek Ventures and as a senior auditor at Arthur Andersen.
John Perkins has joined Ampersand as an operating partner, where he will work with the investment team to identify and evaluate new platform opportunities. Most recently, Perkins served as a senior executive at Ampersand portfolio company Talecris Biotherapeutics, which was acquired by Grifols in 2011. Prior to Talecris, Perkins held roles as an operating executive at Cerberus and as an executive at General Electric.
"Ampersand has been making successful middle-market healthcare investments for 20 years, and these key additions further build on our strong base of healthcare investment experience and operating talent," says Herb Hooper, Ampersand managing partner.
